TY - JOUR
T1 - Estimating the long-term costs of diabetic kidney disease: an economic approach
AU - Knezevic, M.A.
PY - 2009
Y1 - 2009
N2 - Healthcare spending in Australia has increased rapidly in recent decades,partly due to the prevalence of lifestyle related illness, as physical inactivityand ageing have become common. Diabetes is a chronic and costly illnessresulting from poor lifestyle choice and ageing. In this study, we estimatethe long-run cumulative costs of a complication of diabetes, diabetickidney disease, using well-known techniques from health economics.We find that spending on treatment for diabetic kidney disease will amountto $9.2 billion over the next 30 years. Most of the cost from thiscomplication comes from the clinical stage of diabetic kidney disease.
AB - Healthcare spending in Australia has increased rapidly in recent decades,partly due to the prevalence of lifestyle related illness, as physical inactivityand ageing have become common. Diabetes is a chronic and costly illnessresulting from poor lifestyle choice and ageing. In this study, we estimatethe long-run cumulative costs of a complication of diabetes, diabetickidney disease, using well-known techniques from health economics.We find that spending on treatment for diabetic kidney disease will amountto $9.2 billion over the next 30 years. Most of the cost from thiscomplication comes from the clinical stage of diabetic kidney disease.
U2 - 10.1080/13504850701335301
DO - 10.1080/13504850701335301
M3 - Article
VL - 16
SP - 1059
EP - 1064
JO - Applied Financial Economics Letters
JF - Applied Financial Economics Letters
SN - 1350-4851
IS - 10
ER -